1. Market Research
  2. > Business Services
  3. > Research and Development Market Trends
  4. > BioApex, s.r.o. - Product Pipeline Review - 2014

BioApex, s.r.o. - Product Pipeline Review - 2014

  • December 2014
  • -
  • Global Markets Direct
  • -
  • 19 pages

BioApex, s.r.o. - Product Pipeline Review - 2014

Summary

Global Markets Direct’s, ‘BioApex, s.r.o. - Product Pipeline Review - 2014’, provides an overview of the BioApex, s.r.o.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of BioApex, s.r.o.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of BioApex, s.r.o. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of BioApex, s.r.o.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the BioApex, s.r.o.’s pipeline products

Reasons to buy

- Evaluate BioApex, s.r.o.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of BioApex, s.r.o. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the BioApex, s.r.o.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of BioApex, s.r.o. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of BioApex, s.r.o.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of BioApex, s.r.o. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table Of Contents

BioApex, s.r.o. - Product Pipeline Review - 2014
Table of Contents
BioApex, s.r.o. Snapshot 4
BioApex, s.r.o. Overview 4
Key Information 4
Key Facts 4
BioApex, s.r.o. - Research and Development Overview 5
Key Therapeutic Areas 5
BioApex, s.r.o. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
BioApex, s.r.o. - Pipeline Products Glance 9
BioApex, s.r.o. - Early Stage Pipeline Products 9
Preclinical Products/Combination Treatment Modalities 9
BioApex, s.r.o. - Drug Profiles 10
BA-1248 10
Product Description 10
Mechanism of Action 10
RandD Progress 10
BA-2123 11
Product Description 11
Mechanism of Action 11
RandD Progress 11
BA-368 12
Product Description 12
Mechanism of Action 12
RandD Progress 12
BioApex, s.r.o. - Pipeline Analysis 13
BioApex, s.r.o. - Pipeline Products by Target 13
BioApex, s.r.o. - Pipeline Products by Route of Administration 14
BioApex, s.r.o. - Pipeline Products by Molecule Type 15
BioApex, s.r.o. - Pipeline Products by Mechanism of Action 16
BioApex, s.r.o. - Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
Coverage 18
Secondary Research 18
Primary Research 18
Expert Panel Validation 18
Contact Us 19
Disclaimer 19

List of Tables

BioApex, s.r.o., Key Information 4
BioApex, s.r.o., Key Facts 4
BioApex, s.r.o. - Pipeline by Indication, 2014 6
BioApex, s.r.o. - Pipeline by Stage of Development, 2014 7
BioApex, s.r.o. - Monotherapy Products in Pipeline, 2014 8
BioApex, s.r.o. - Preclinical, 2014 9
BioApex, s.r.o. - Pipeline by Target, 2014 13
BioApex, s.r.o. - Pipeline by Route of Administration, 2014 14
BioApex, s.r.o. - Pipeline by Molecule Type, 2014 15
BioApex, s.r.o. - Pipeline Products by Mechanism of Action, 2014 16

List of Figures

BioApex, s.r.o. - Pipeline by Top 10 Indication, 2014 6
BioApex, s.r.o. - Pipeline by Top 10 Target, 2014 13
BioApex, s.r.o. - Pipeline Products by Top 10 Mechanism of Action, 2014 16

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Eosinophil Peroxidase (EPO or EPX or EC 1.11.1.7) - Pipeline Review, H2 2016

Eosinophil Peroxidase (EPO or EPX or EC 1.11.1.7) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • December 2016
  • by Global Markets Direct

Eosinophil Peroxidase (EPO or EPX or EC 1.11.1.7) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Eosinophil Peroxidase (EPO or EPX or EC 1.11.1.7) - Pipeline Review, H2 2016’, provides ...

ADC Therapeutics SA - Product Pipeline Review - 2016

ADC Therapeutics SA - Product Pipeline Review - 2016

  • $ 1500
  • Company report
  • November 2016
  • by Global Markets Direct

ADC Therapeutics SA - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘ADC Therapeutics SA - Product Pipeline Review - 2016’, provides an overview of the ADC Therapeutics SA’s pharmaceutical ...

PharmAbcine Inc - Product Pipeline Review - 2016

PharmAbcine Inc - Product Pipeline Review - 2016

  • $ 1500
  • Company report
  • December 2016
  • by Global Markets Direct

PharmAbcine Inc - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘PharmAbcine Inc - Product Pipeline Review - 2016’, provides an overview of the PharmAbcine Inc’s pharmaceutical ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.